These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 27227955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL, Wang Y, Liang SB, He SS, Chen DM, Chen HY, Lu LX, Chen Y.
    BMC Cancer; 2018 May 29; 18(1):606. PubMed ID: 29843648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW.
    Oncotarget; 2017 Feb 21; 8(8):14068-14077. PubMed ID: 27764778
    [Abstract] [Full Text] [Related]

  • 6. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Feng M, Wang W, Fan Z, Fu B, Li J, Zhang S, Lang J.
    Radiat Oncol; 2013 Sep 05; 8():208. PubMed ID: 24007375
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX, Wang Y, Cao PF, Shen L, Zhao YJ, Zhang ZJ, Chen DM, Yang TB, Huang XQ, Qin Z, Dai YY, Shen LF.
    Chin J Cancer; 2016 Nov 16; 35(1):96. PubMed ID: 27852284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J, Lin S, Lin J, Tang L, Chen B, Zhang M, Zhang Y, Xu L, Chen Y, Xiao Y, Fang Y, Pan J.
    Oral Oncol; 2015 Mar 16; 51(3):254-9. PubMed ID: 25467207
    [Abstract] [Full Text] [Related]

  • 10. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y, Hu XF, Wang Y, Chen HY, Yang L, Liu LZ, Cui CY, Liu DS, Liang SB.
    BMC Cancer; 2015 Apr 18; 15():305. PubMed ID: 25903652
    [Abstract] [Full Text] [Related]

  • 11. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY.
    Eur J Cancer; 2015 Nov 18; 51(17):2587-95. PubMed ID: 26318726
    [Abstract] [Full Text] [Related]

  • 12. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
    Liu K, Han Y, Ma B.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov 18; 27(21):1177-83. PubMed ID: 24616996
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y, Pan J, Chen Y, Lin S, Chen Y, Zong J, Fang Y, Guo Q, Chen B, Tang L.
    Radiat Oncol; 2015 Sep 25; 10():204. PubMed ID: 26407897
    [Abstract] [Full Text] [Related]

  • 14. Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
    Zeng L, Tian YM, Sun XM, Huang Y, Chen CY, Han F, Liu S, Lan M, Guan Y, Deng XW, Lu TX.
    Strahlenther Onkol; 2014 Oct 25; 190(11):993-1000. PubMed ID: 24838409
    [Abstract] [Full Text] [Related]

  • 15. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL, Zhou GQ, Li YY, Tang LL, Mao YP, Lin AH, Ma J, Qi ZY, Sun Y.
    Cancer Med; 2017 Dec 25; 6(12):2822-2831. PubMed ID: 29034992
    [Abstract] [Full Text] [Related]

  • 16. A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.
    Zhou Q, He Y, Zhao Y, Wang Y, Kuang W, Shen L.
    Biomed Res Int; 2017 Dec 25; 2017():1419676. PubMed ID: 28265567
    [Abstract] [Full Text] [Related]

  • 17. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P, Min Y, Blanchard P, Feng M, Zhang P, Luo Y, Fan Z, Lang J.
    Head Neck; 2017 Feb 25; 39(2):305-310. PubMed ID: 27627795
    [Abstract] [Full Text] [Related]

  • 18. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
    Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, Mao YP, Liu LZ, Li L, Lin AH, Ma J.
    Radiother Oncol; 2012 Sep 25; 104(3):294-9. PubMed ID: 22998947
    [Abstract] [Full Text] [Related]

  • 19. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF, Zhang WB, Ke SB, Zhao F, Yan SX, Wang QD, Teng LS.
    BMC Cancer; 2017 Oct 11; 17(1):678. PubMed ID: 29020937
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Mao YP, Tang LL, Chen L, Sun Y, Qi ZY, Zhou GQ, Liu LZ, Li L, Lin AH, Ma J.
    Chin J Cancer; 2016 Dec 28; 35(1):103. PubMed ID: 28031050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.